This title appears in the Scientific Report :
2022
Please use the identifier:
http://hdl.handle.net/2128/31829 in citations.
Please use the identifier: http://dx.doi.org/10.3390/cancers14051240 in citations.
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups
Saved in:
Personal Name(s): | Trommer, Maike (Corresponding author) |
---|---|
Adams, Anne / Celik, Eren / Fan, Jiaqi / Funken, Dominik / Herter, Jan M. / Linde, Philipp / Morgenthaler, Janis / Wegen, Simone / Mauch, Cornelia / Franklin, Cindy / Galldiks, Norbert / Werner, Jan-Michael / Kocher, Martin / Rueß, Daniel / Ruge, Maximilian / Meißner, Anna-Katharina / Baues, Christian / Marnitz, Simone | |
Contributing Institute: |
Kognitive Neurowissenschaften; INM-3 |
Published in: | Cancers, 14 (2022) 5, S. 1240 - |
Imprint: |
Basel
MDPI
2022
|
DOI: |
10.3390/cancers14051240 |
Document Type: |
Journal Article |
Research Program: |
Brain Dysfunction and Plasticity |
Link: |
OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.3390/cancers14051240 in citations.
Description not available. |